50 results
8-K
EX-2.1
ALIM
Alimera Sciences Inc.
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
to the non-performing Party’s respective employees or agents), fire, floods, pandemic, earthquakes or other acts of God, or any generally applicable
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
31 Mar 23
Alimera Sciences Announces 2022 Financial Results and Business Update
8:43am
for 2021. The increase was predominantly due to our decision to invest in growth as we emerged from the pandemic to regain commercial momentum.
Cash
8-K
vjt82o0mzox966djdz
14 Nov 22
Alimera Sciences Announces Third Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
4dte zjbadqb
14 Nov 22
Alimera Sciences Announces Third Quarter 2022 Financial Results
8:34am
8-K
xefl8zie4lkad1t7c0c
27 Jul 22
Alimera Sciences Announces Second Quarter 2022 Financial Results
8:22am
8-K
EX-99.1
vusqonji hll35ong0
27 Jul 22
Alimera Sciences Announces Second Quarter 2022 Financial Results
8:22am
8-K
fe1m2
7 Jun 22
Regulation FD Disclosure
8:56am
8-K
i6lpbpc
9 May 22
Alimera Sciences Reports First Quarter 2022 Results
8:40am
8-K
EX-99.1
o37yf3v1wecx219 fex
9 May 22
Alimera Sciences Reports First Quarter 2022 Results
8:40am
8-K
EX-99.1
zs1y 41jtvv1kh
24 Feb 22
Alimera Sciences Reports Fourth Quarter and FY 2021 Results
8:15am
8-K
dcl8yzh8q8so yrt
24 Feb 22
Alimera Sciences Reports Fourth Quarter and FY 2021 Results
8:15am